NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
TuesdayDec 10, 2019 6:20 pm

Medicenna Therapeutics Corp. (TSX: MDNA) (MDNAF) Starts Presentation at 12th Annual LD Micro Main Event

Medicenna Therapeutics (TSX: MDNA) (OTCQB: MDNAF) is a clinical-stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad range of cancers. Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna's lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the U.S. MDNA55 has been studied in…

Continue Reading

TuesdayDec 10, 2019 6:20 pm

Perion Network Ltd. (NASDAQ: PERI) Starts Presentation at 12th Annual LD Micro Main Event

Perion Network (NASDAQ: PERI) delivers data-driven online advertising and search solutions to brands and publishers. The company’s high-impact advertising division, Undertone, helps brands capture consumer attention via beautiful creative and proprietary ad formats served across top-tier publishers. Perion’s search division, CodeFuel, enables developers to optimize search traffic and generate incremental revenue. The company’s social advertising platform, MakeMeReach, drives marketing campaigns and demand generation at scale across Facebook, Twitter, Instagram and Snapchat. Perion’s ‘owned and operated’ consumer apps division delivers powerful and engaging mobile and desktop apps direct to consumers. For more information, visit the company’s website at www.perion.com. About NetworkNewsWire…

Continue Reading

TuesdayDec 10, 2019 6:20 pm

Dolphin Entertainment Inc. (NASDAQ: DLPN) Starts Presentation at 12th Annual LD Micro Main Event

Dolphin Entertainment (NASDAQ: DLPN) is an independent entertainment marketing and premium content development company. Through its subsidiaries, 42West and The Door, the company provides expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the entertainment and hospitality industries. Dolphin's recent acquisition of Viewpoint Creative adds full-service creative branding and production capabilities to the company’s marketing group. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series. For more information, visit the company’s website at www.dolphinentertainment.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

Continue Reading

TuesdayDec 10, 2019 6:00 pm

LightPath Technologies Inc. (NASDAQ: LPTH) Starts Presentation at 12th Annual LD Micro Main Event

LightPath Technologies (NASDAQ: LPTH) is a global, vertically integrated provider of optics, photonics and infrared solutions for the industrial, commercial, defense, telecommunications and medical industries. LightPath designs, manufactures and distributes proprietary optical and infrared components including molded glass aspheric lenses and assemblies, infrared lenses and thermal imaging assemblies, fused fiber collimators, and proprietary Black DiamondTM (“BD6”) chalcogenide-based glass lenses. LightPath also offers custom optical assemblies, including full engineering design support. The company is headquartered in Orlando, Florida, with manufacturing and sales offices in Latvia and China. For more information, visit the company’s website at www.lightpath.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

TuesdayDec 10, 2019 6:00 pm

U.S. Nuclear Corp. (UCLE) Starts Presentation at 12th Annual LD Micro Main Event

US Nuclear’s (OTCQB: UCLE) operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia, and others. For more information,…

Continue Reading

TuesdayDec 10, 2019 6:00 pm

BioLargo Inc. (BLGO) Starts Presentation at 12th Annual LD Micro Main Event

BioLargo (OTCQB: BLGO) invents, patents and develops innovative platform technologies for three markets: advanced water and wastewater treatment, industrial odor and VOC control, and advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity.  BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies. For more information, visit the company’s website at www.biolargo.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) Starts Presentation at 12th Annual LD Micro Main Event

DelMar Pharmaceuticals (NASDAQ: DMPI) is a biopharmaceutical company focused on the development and commercialization of new cancer therapies. The company’s lead product candidate, VAL-083, is a "first-in-class" small molecule DNA-targeting agent that is currently being evaluated in a biomarker-driven, Phase 2 clinical trial for the treatment of Unmethylated MGMT recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. The company is also exploring VAL-083 in a Phase 2 trial as a therapy for front-line Unmethylated MGMT GBM and we may study other solid tumors, including ovarian cancer and pediatric CNS tumors. For more information, visit the…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Novus Therapeutics Inc. (NASDAQ: NVUS) Starts Presentation at 12th Annual LD Micro Main Event

Novus Therapeutics (NASDAQ: NVUS) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is being developed as a potential first-in-class treatment option for patients at risk for, or with, otitis media (“OM”) or middle ear inflammation with or without infection. OM is one of the most common disorders seen in pediatric practice, and in the U.S. it is a leading cause of health care visits; and the most…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Artelo Biosciences Inc. (NASDAQ: ARTL) Starts Presentation at 12th Annual LD Micro Main Event

Artelo Biosciences (NASDAQ: ARTL) is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. The company’s programs have the potential to dramatically improve patient care in major markets. Artelo’s science-based approach rests on three pillars that uniquely position the company for growth: an unwavering dedication to letting the science lead; a portfolio-based, de-risked and nimble business strategy; and an experienced leadership team with proven performance in regulated drug development and global commercialization. For more information, visit…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Wow! Unlimited Media Inc. (TSXV: WOW) (WOWMF) Starts Presentation at 12th Annual LD Micro Main Event

WOW! Unlimited Media (TSXV: WOW) (OTCQX: WOWMF), is creating an animation-focused, multi-platform entertainment company by producing top-end content, and building brands and audiences on the most engaging media platforms. The company produces animation in its two established studios: Frederator Studios in Los Angeles, which has a 20-year track record; and Mainframe Studios in Vancouver, one of Canada's largest, multi-faceted animation production studios, which has a 25-year track record. The company’s media assets include Channel Frederator Network on YouTube, as well as WOW! branded programming on Crave, Canada’s leading streaming entertainment platform, owned by Bell Media. The company operates out of…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers